Novacyt secures further funding of up to 5 million euros

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, announces that it has secured flexible bond financing for a maximum of 5 million euros over three years, as part of a private placement underwritten by the YA Global Master SPV Ltd fund.

Download press release